<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Lorenzen Dueholm | Activity</title>
	<link>https://www.catswannabecats.com/members/eightsense69/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/eightsense69/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lorenzen Dueholm.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">af585d4f95ea410c99ead438065f9a09</guid>
				<title>Lorenzen Dueholm posted an update: The postmarketing assessment of biosimilars is important [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23537/</link>
				<pubDate>Sun, 08 Jun 2025 09:27:46 -0400</pubDate>

									<content:encoded><![CDATA[<p>The postmarketing assessment of biosimilars is important because posttranslational modification by glycosylation is altered by the manufacturing process. A retrospective study of 15 patients with gastric cancer receiving a combination anticancer therapy with trastuzumab was performed. The most common concurrent regimen was the S-1 and oxaliplatin&hellip;<span class="activity-read-more" id="activity-read-more-23537"><a href="https://www.catswannabecats.com/activity/p/23537/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a2b837223ea7f29075161cdca8315b38</guid>
				<title>Lorenzen Dueholm posted an update: 4%). The common possible contributors include use of a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11988/</link>
				<pubDate>Sun, 01 Jun 2025 08:33:22 -0400</pubDate>

									<content:encoded><![CDATA[<p>4%). The common possible contributors include use of a stylet, cuff overdistention, multiple attempts to adjust the position of a DLT, difficult intubation, and use of an oversized DLT. Most of the airway ruptures were diagnosed intraoperatively (n = 138, 82.7%). Pneumomediastinum, air leakage, hypoxemia, and subcutaneous emphysema were the common&hellip;<span class="activity-read-more" id="activity-read-more-11988"><a href="https://www.catswannabecats.com/activity/p/11988/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7e859fceedb13eb59ae72f3d3c70c8b5</guid>
				<title>Lorenzen Dueholm posted an update: In this way, AgNWs can be used as a potential tool to verify [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5304/</link>
				<pubDate>Sat, 31 May 2025 14:43:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>In this way, AgNWs can be used as a potential tool to verify biological reactions, such as modulation of metabolic pathways, together with the evaluation of a possible influence of biotic or abiotic factors in organisms.Graphene nanoribbons (GNR) with intrinsic peroxidase mimic activity were introduced as a nanozyme with catalytic activity in&hellip;<span class="activity-read-more" id="activity-read-more-5304"><a href="https://www.catswannabecats.com/activity/p/5304/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">039f85969bf04ab38c5b07f4f586705f</guid>
				<title>Lorenzen Dueholm became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4991/</link>
				<pubDate>Sat, 31 May 2025 14:21:46 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>